Spineway (ALSPW.PA) Stock Price

Spineway Price

Euronext·CLOSED
0.11
​
Market closed

Over the last 16 years Spineway grew revenue by 10.9% annually, reaching 12.43 M EUR. For Spineway, the net margin of -18.0% is up versus -36.9% a few years ago. The consensus 12-month price target for Spineway is 0.31 EUR, about 190.9% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.

Spineway stock price

Access this data via the Eulerpool API

Spineway business model & stock analysis

Spineway SA is engaged in the design, production, and sale of spinal column implants and surgical instruments. The company is headquartered in Ecully, Auvergne-Rhone-Alpes and currently employs 35 full-time employees. The company went IPO on 2013-02-08. The company designs, produces and sells spinal column implants and surgical instruments. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, among others.

Frequently asked questions about Spineway

Analysts currently set an average price target of 0.31 EUR for the Spineway stock (median: 0.31 EUR), implying +190.9 % versus the latest price. The consensus is based on 9 analyst ratings.

9 analysts currently rate the Spineway stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Spineway to generate revenue of 13.20 M EUR and earnings per share of -0.05 EUR.

The Spineway share (ALSPW.PA) is listed on 4 stock exchanges, including: Frankfurt (37S.F), München (37S.MU), Paris (ALSPW.PA).

The expected revenue of Spineway is 13.20 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Spineway is -1.73 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Spineway is currently -2.17. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Spineway stock.

The price-to-sales ratio (P/S) of Spineway is currently 0.28. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Spineway stock.

The Eulerpool Quality Score for Spineway is 4/10.

The ISIN of Spineway is FR001400N2P2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Spineway is A1KCX1. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Spineway is ALSPW.PA. The ticker symbol is used to trade Spineway shares on the stock exchange.

Fair ValueTerminal
0.09 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
355,142.86 EUR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website spineway.com
Country
Currency
EUR
Initial public offering
Feb 8, 2013
ISIN
FR001400N2P2
Cusip
F86930108
Sedol
B9J98D9
Market capitalization
3.03 M EURMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-2.17
P/Ee 2027
-2.17
P/S
P/Se
0.28
EV/EBIT
—
P/B Ratio
0.13
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-9.10 %
Last updated Oct 11, 2026, 10:08 AM

Spineway Ticker

EURONEXT · ALSPW.PAFRANKFURT · 37S.FMUNICH · 37S.MUPARIS · ALSPW.PA

All fundamentals and in-depth analysis of Spineway

Our stock analysis for Spineway stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Spineway. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.